Prognostic	0	10	O
value	11	16	O
of	17	19	O
angiogenesis	20	32	O
in	33	35	O
operable	36	44	O
non	45	48	B-Pathological_formation
-	48	49	I-Pathological_formation
small	49	54	I-Pathological_formation
cell	55	59	I-Pathological_formation
lung	60	64	I-Pathological_formation
cancer	65	71	I-Pathological_formation
.	71	72	O

Tumour	74	80	B-Pathological_formation
angiogenesis	81	93	O
is	94	96	O
an	97	99	O
important	100	109	O
factor	110	116	O
for	117	120	O
tumour	121	127	B-Pathological_formation
growth	128	134	O
and	135	138	O
metastasis	139	149	O
.	149	150	O

Although	151	159	O
some	160	164	O
recent	165	171	O
reports	172	179	O
suggest	180	187	O
that	188	192	O
microvessel	193	204	B-Tissue
counts	205	211	O
in	212	214	O
non	215	218	B-Pathological_formation
-	218	219	I-Pathological_formation
small	219	224	I-Pathological_formation
cell	225	229	I-Pathological_formation
lung	230	234	I-Pathological_formation
cancer	235	241	I-Pathological_formation
are	242	245	O
related	246	253	O
to	254	256	O
a	257	258	O
poor	259	263	O
disease	264	271	O
outcome	272	279	O
,	279	280	O
the	281	284	O
results	285	292	O
were	293	297	O
not	298	301	O
conclusive	302	312	O
and	313	316	O
were	317	321	O
not	322	325	O
compared	326	334	O
with	335	339	O
other	340	345	O
molecular	346	355	O
prognostic	356	366	O
markers	367	374	O
.	374	375	O

In	376	378	O
the	379	382	O
present	383	390	O
study	391	396	O
,	396	397	O
the	398	401	O
vascular	402	410	O
grade	411	416	O
was	417	420	O
assessed	421	429	O
in	430	432	O
107	433	436	O
(	437	438	O
T1	438	440	O
,	440	441	O
2	441	442	O
-	442	443	O
N0	443	445	O
,	445	446	O
1	446	447	O
)	447	448	O
operable	449	457	O
non	458	461	B-Pathological_formation
-	461	462	I-Pathological_formation
small	462	467	I-Pathological_formation
cell	468	472	I-Pathological_formation
lung	473	477	I-Pathological_formation
carcinomas	478	488	I-Pathological_formation
,	488	489	O
using	490	495	O
the	496	499	O
JC70	500	504	O
monoclonal	505	515	O
antibody	516	524	O
to	525	527	O
CD31	528	532	B-Gene_or_gene_product
.	532	533	O

Three	534	539	O
vascular	540	548	O
grades	549	555	O
were	556	560	O
defined	561	568	O
with	569	573	O
appraisal	574	583	O
by	584	586	O
eye	587	590	B-Organ
and	591	594	O
by	595	597	O
Chalkley	598	606	O
counting	607	615	O
:	615	616	O
high	617	621	O
(	622	623	O
Chalkley	623	631	O
score	632	637	O
7	638	639	O
-	639	640	O
12	640	642	O
)	642	643	O
,	643	644	O
medium	645	651	O
(	652	653	O
5	653	654	O
-	654	655	O
6	655	656	O
)	656	657	O
,	657	658	O
and	659	662	O
low	663	666	O
(	667	668	O
2	668	669	O
-	669	670	O
4	670	671	O
)	671	672	O
.	672	673	O

There	674	679	O
was	680	683	O
a	684	685	O
significant	686	697	O
correlation	698	709	O
between	710	717	O
eye	718	721	B-Organ
appraisal	722	731	O
and	732	735	O
Chalkley	736	744	O
counting	745	753	O
(	754	755	O
P	755	756	O
less	758	762	O
than	763	767	O
0	769	770	O
.	770	771	O
0001	771	775	O
)	775	776	O
.	776	777	O

Vascular	778	786	O
grade	787	792	O
was	793	796	O
not	797	800	O
related	801	808	O
to	809	811	O
histology	812	821	O
,	821	822	O
grade	823	828	O
,	828	829	O
proliferation	830	843	O
index	844	849	O
(	850	851	O
Ki67	851	855	B-Gene_or_gene_product
)	855	856	O
,	856	857	O
or	858	860	O
EGFR	861	865	B-Gene_or_gene_product
or	866	868	O
p53	869	872	B-Gene_or_gene_product
expression	873	883	O
.	883	884	O

Tumours	885	892	B-Pathological_formation
from	893	897	O
younger	898	905	O
patients	906	914	B-Organism
had	915	918	O
a	919	920	O
higher	921	927	O
grade	928	933	O
of	934	936	O
angiogenesis	937	949	O
(	950	951	O
P	951	952	O
=	953	954	O
0	955	956	O
.	956	957	O
05	957	959	O
)	959	960	O
.	960	961	O

Apart	962	967	O
from	968	972	O
the	973	976	O
vascular	977	985	O
grade	986	991	O
,	991	992	O
none	993	997	O
of	998	1000	O
the	1001	1004	O
other	1005	1010	O
factors	1011	1018	O
examined	1019	1027	O
was	1028	1031	O
statistically	1032	1045	O
related	1046	1053	O
to	1054	1056	O
lymph	1057	1062	B-Multi-tissue_structure
node	1063	1067	I-Multi-tissue_structure
metastasis	1068	1078	O
(	1079	1080	O
P	1080	1081	O
less	1083	1087	O
than	1088	1092	O
0	1094	1095	O
.	1095	1096	O
0001	1096	1100	O
)	1100	1101	O
.	1101	1102	O

A	1103	1104	O
univariate	1105	1115	O
analysis	1116	1124	O
of	1125	1127	O
survival	1128	1136	O
showed	1137	1143	O
that	1144	1148	O
vascular	1149	1157	O
grade	1158	1163	O
was	1164	1167	O
the	1168	1171	O
most	1172	1176	O
significant	1177	1188	O
prognostic	1189	1199	O
factor	1200	1206	O
(	1207	1208	O
P	1208	1209	O
=	1210	1211	O
0	1212	1213	O
.	1213	1214	O
0004	1214	1218	O
)	1218	1219	O
,	1219	1220	O
followed	1221	1229	O
by	1230	1232	O
N	1233	1234	O
-	1234	1235	O
stage	1235	1240	O
(	1241	1242	O
P	1242	1243	O
=	1244	1245	O
0	1246	1247	O
.	1247	1248	O
001	1248	1251	O
)	1251	1252	O
.	1252	1253	O

In	1254	1256	O
a	1257	1258	O
multivariate	1259	1271	O
analysis	1272	1280	O
,	1280	1281	O
N	1282	1283	O
-	1283	1284	O
stage	1284	1289	O
and	1290	1293	O
vascular	1294	1302	O
grade	1303	1308	O
were	1309	1313	O
not	1314	1317	O
found	1318	1323	O
to	1324	1326	O
be	1327	1329	O
independent	1330	1341	O
prognostic	1342	1352	O
factors	1353	1360	O
,	1360	1361	O
since	1362	1367	O
they	1368	1372	O
were	1373	1377	O
strongly	1378	1386	O
related	1387	1394	O
to	1395	1397	O
each	1398	1402	O
other	1403	1408	O
.	1408	1409	O

Excluding	1410	1419	O
N	1420	1421	O
-	1421	1422	O
stage	1422	1427	O
,	1427	1428	O
vascular	1429	1437	O
grade	1438	1443	O
was	1444	1447	O
the	1448	1451	O
only	1452	1456	O
independent	1457	1468	O
prognostic	1469	1479	O
factor	1480	1486	O
(	1487	1488	O
P	1488	1489	O
=	1490	1491	O
0	1492	1493	O
.	1493	1494	O
007	1494	1497	O
)	1497	1498	O
.	1498	1499	O

Kaplan	1500	1506	O
-	1506	1507	O
Meier	1507	1512	O
survival	1513	1521	O
curves	1522	1528	O
showed	1529	1535	O
a	1536	1537	O
statistically	1538	1551	O
significant	1552	1563	O
worse	1564	1569	O
prognosis	1570	1579	O
for	1580	1583	O
patients	1584	1592	B-Organism
with	1593	1597	O
high	1598	1602	O
vascular	1603	1611	O
grade	1612	1617	O
,	1617	1618	O
but	1619	1622	O
no	1623	1625	O
difference	1626	1636	O
was	1637	1640	O
observed	1641	1649	O
between	1650	1657	O
low	1658	1661	O
and	1662	1665	O
medium	1666	1672	O
vascular	1673	1681	O
grade	1682	1687	O
.	1687	1688	O

These	1689	1694	O
data	1695	1699	O
suggest	1700	1707	O
that	1708	1712	O
angiogenesis	1713	1725	O
in	1726	1728	O
operable	1729	1737	O
non	1738	1741	B-Pathological_formation
-	1741	1742	I-Pathological_formation
small	1742	1747	I-Pathological_formation
cell	1748	1752	I-Pathological_formation
lung	1753	1757	I-Pathological_formation
cancer	1758	1764	I-Pathological_formation
is	1765	1767	O
a	1768	1769	O
major	1770	1775	O
prognostic	1776	1786	O
factor	1787	1793	O
for	1794	1797	O
survival	1798	1806	O
and	1807	1810	O
,	1810	1811	O
among	1812	1817	O
the	1818	1821	O
parameters	1822	1832	O
tested	1833	1839	O
,	1839	1840	O
is	1841	1843	O
the	1844	1847	O
only	1848	1852	O
factor	1853	1859	O
related	1860	1867	O
to	1868	1870	O
cancer	1871	1877	B-Cell
cell	1878	1882	I-Cell
migration	1883	1892	O
to	1893	1895	O
lymph	1896	1901	B-Multi-tissue_structure
nodes	1902	1907	I-Multi-tissue_structure
.	1907	1908	O

The	1909	1912	O
integration	1913	1924	O
of	1925	1927	O
vascular	1928	1936	O
grading	1937	1944	O
in	1945	1947	O
clinical	1948	1956	O
trials	1957	1963	O
on	1964	1966	O
adjuvant	1967	1975	O
chemotherapy	1976	1988	O
and	1989	1992	O
/	1992	1993	O
or	1993	1995	O
radiotherapy	1996	2008	O
could	2009	2014	O
substantially	2015	2028	O
contribute	2029	2039	O
in	2040	2042	O
defining	2043	2051	O
groups	2052	2058	O
of	2059	2061	O
operable	2062	2070	O
patients	2071	2079	B-Organism
who	2080	2083	O
might	2084	2089	O
benefit	2090	2097	O
from	2098	2102	O
cytotoxic	2103	2112	O
treatment	2113	2122	O
.	2122	2123	O

